Switching from a ritonavir-boosted PI to dolutegravir as an alternative strategy in virologically suppressed HIV-infected individuals

  1. Negredo, E.
  2. Estrada, V.
  3. Domingo, P.
  4. Gutierrez, M.D.M.
  5. Mateo, G.M.
  6. Puig, J.
  7. Bonjoch, A.
  8. Ornelas, A.
  9. Echeverriá, P.
  10. Estany, C.
  11. Toro, J.
  12. Clotet, B.
Aldizkaria:
Journal of Antimicrobial Chemotherapy

ISSN: 1460-2091,  0305-7453

Argitalpen urtea: 2017

Alea: 72

Zenbakia: 3

Orrialdeak: 844-849

Mota: Artikulua

DOI: 10.1093/JAC/DKW504 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus